Venetoclax treatment outcomes and patterns of use in relapsed/refractory chronic lymphocytic leukemia (CLL) under routine clinical practice in Saudi Arabia and Gulf countries

Study Identifier
P21-187
CT.gov Identifier
Not available
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Not available
Sign up for trial alerts

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Blood Cancer - Leukemia (Other)
    • Study Drug
    N/A
    Phase
    Other
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria

    Protocol Summary

    To assess the treatment outcomes and patterns of use of venetoclax regimens in relapsed/refractory chronic lymphocytic leukemia under routine practice

    Study Locations

    No locations found.